Periodontal Medicament Delivery Tray for Targeted Periopathogen Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating periodontal disease are often ineffective in addressing the systemic effects of periodontal originated diseases, as they fail to provide long-lasting reductions in systemic biomarkers, which frequently return to elevated pre-treatment levels after conventional oral disinfection.
Innovation Solution
A method and system for treating and controlling oral periopathogens involve evaluating treatment regions for specific bacterial communities and biofilms, preparing a periodontal medicament delivery tray with application regions for targeted medicament application, and selecting medicaments based on their efficacy against determined bacterial communities to inhibit systemic inflammation and disease.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional oral disinfection methods are used to treat periodontal disease, then short-term reduction in bacterial load is achieved, but systemic biomarkers return to elevated pre-treatment levels
Solution Approach 1:
The system performs preliminary identification of specific bacterial communities and biofilm characteristics before treatment, allowing selection of appropriate medicaments in advance. This preliminary characterization enables targeted therapy that addresses the root cause of persistent inflammation, preventing biomarker recurrence.
Solution Approach 2:
The invention applies different medicaments to different treatment regions based on the specific bacterial communities and biofilm types present in each region. This localized, customized approach ensures that each area receives the most effective treatment, leading to sustained systemic inflammation control.
2Reliability
If broad-spectrum oral disinfection is applied to all treatment regions, then general bacterial load is reduced, but specific periopathogens causing systemic inflammation persist
Solution Approach 1:
The system identifies and treats different treatment regions with specific medicaments matched to the local bacterial community composition and biofilm characteristics. This precise, region-specific approach ensures that the particular periopathogens responsible for systemic inflammation are targeted effectively, rather than using uniform broad-spectrum treatment.
Solution Approach 2:
The system uses feedback from bacterial identification and biofilm characterization to guide medicament selection and treatment strategy. This closed-loop approach allows continuous adjustment of treatment to maintain effectiveness against evolving bacterial communities, ensuring sustained control of systemic markers.
3Reliability
If intensive periodontal treatment with multiple medicaments is applied, then periopathogen reduction is enhanced, but treatment complexity and patient compliance difficulty increase
Solution Approach 1:
The treatment system is segmented into distinct treatment regions, each addressed with a specific medicament selection based on local bacterial and biofilm characteristics. This segmentation allows complex multi-medicament therapy to be organized into manageable, region-specific protocols that are easier to implement and monitor.
Solution Approach 2:
The system enables patient self-monitoring and self-management through simplified protocols and clear instructions for each treatment region. By organizing treatment into discrete, region-specific steps based on initial assessment, patients can more easily comply with the regimen without being overwhelmed by overall treatment complexity.
Data Source
AI summary
Methods and systems for treating and controlling oral periopathogens that have been found to be associated with systemic inflammation and/or disease in a periodontal pocket, inhibiting their entry into the host circulatory system, and decreasing the systemic effects. A bacterial community present in one or more oral treatment regions is determined. A periodontal medicament delivery tray is prepared for the patient with the delivery tray being configured with one or more application regions, each configured for applying a medicament to a different one of the oral treatment regions. The medicaments are applied to each oral treatment region, including placing each medicament into a different application region of the delivery tray. Each of the applied medicaments is applied as a function of a determined efficacy of the medicament against the bacterial community determined to be in the oral treatment region associated with the application region in which each medicament is applied.